Improved Quality of Life, Clinical, and Psychosocial Outcomes Among Heroin-dependent Patients on Ambulatory Buprenorphine Maintenance

References

• Ahmadi, J. (2003). Methadone versus buprenorphine maintenance for the treatment of heroin-dependent outpatients. Journal of Substance Abuse Treatment, 24:217–220.
   PubMed Web of Science ®Google Scholar
• Amato, L., Davoli, M. A., Perucci, C., Ferri, M., Faggiano, F. P., Mattick, R. (2005). An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research. Journal of Substance Abuse Treatment, 28:321–329.
   PubMed Web of Science ®Google Scholar
• Bandura, A. (1994). Self-efficacy. In V. S. Ramachaudran (Ed.), Encyclopedia of human behavior (Vol. 4, pp. 71–81). New York: Academic Press.
   Google Scholar
• Barnett, P. G., Rodgers, J. H., Bloch, D. A. (2001). A meta-analysis comparing buprenorphine to methadone for treatment of opiate dependence. Addiction, 96:683–690.
   PubMed Web of Science ®Google Scholar
• Ben-Ari, A., Gil, S. (2002). Traditional support systems: are they sufficient in a culturally diverse academic environment?? British Journal of Social Work, 32:629–638.
   Google Scholar
• Bosscher, R. J., Smit, J. H. (1998). Confirmatory factor analysis of the General Self-Efficacy Scale. Behaviour Research and Therapy, 36:339–343.
   PubMed Web of Science ®Google Scholar
• Burleson, J. A., Kaminer, Y. (2005). Self-efficacy as a predictor of treatment outcome in adolescent substance use disorders. Addictive Behaviors, 30:1751–1764.
   PubMed Web of Science ®Google Scholar
• Caldiero, R. M., Parran, T. V., Jr., Adelman, C. L., Piche, B. (2006). Inpatient initiation of buprenorphine maintenance vs. detoxification: can retention of opioid-dependent patients in outpatient counseling be improved?? American Journal of Addiction, 15:1–7.
   PubMed Web of Science ®Google Scholar
• Carrieri, M. P., Amass, L., Lucas, G. M., Vlahov, D., Wodak, A., Woody, G. E. (2006). Buprenorphine use: the international experience. Clinical Infectious Diseases, 43(Suppl. 4):197–215.
   Web of Science ®Google Scholar
• Cheskin, L. J., Fudala, P. J., Johnson, R. E. (1994). A controlled comparison of buprenorphine and clonidine for acute detoxification from opioids. Drug and Alcohol Dependence, 36:115–121.
   PubMed Web of Science ®Google Scholar
• Chutuape, M. A., Jasinski, D. R., Fingerhood, M. I., Stitzer, M. L. (2001). One-, three-, and six-month outcomes after brief inpatient opioid detoxification. American Journal of Drug and Alcohol Abuse, 27:19–44.
   PubMed Web of Science ®Google Scholar
• Clark, R. E. (2001). Family support and substance use outcomes for persons with mental illness and substance use disorders. Schizophrenia Bulletin, 27:93–101.
   PubMed Web of Science ®Google Scholar
• Clark, N., Lintzeris, N., Gijsbers, A., Whelan, G. (2003). LAAM maintenance versus methadone maintenance for heroin dependence. Cochrane Review, The Cochrane Library, Issue 3, Oxford, Software update.
   Google Scholar
• Colameco, S., Armando, J., Trotz, C. (2005). Opiate dependence treatment with buprenorphine: one year's experience in a family practice residency setting. Journal of Addictive Disorders, 24:25–32.
   PubMed Web of Science ®Google Scholar
• Cozzolino, E., Guglielmino, L., Vigezzi, P., Marzorati, P., Silenzio, R., De Chiara, M., (2006). Buprenorphine treatment: a three-year prospective study in opioid-addicted patients of a public out-patient addiction center in Milan. American Journal of Addiction, 15:246–251.
   PubMed Web of Science ®Google Scholar
• Duburcq, A., Charpak, Y., Blin, P., Madec, L.,(2000). Two years follow-up of a heroin users cohort treated with high dosage buprenorphine. Results of the SPESUB study (pharmacoepidemiologic follow-up of general practice SUBUTEX). Review of Epidemiology Sante Publique, 48:363–373.
   PubMedGoogle Scholar
• Endicott, J., Nee, J., Harrison, W., Blumenthal, R. (1993). Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacological Bulletin, 29:321–326.
   PubMed Web of Science ®Google Scholar
• Ferri, M., Davoli, M., Perucci, C. A. (2003). Heroin maintenance for chronic heroin dependents. Cochrane Database System Review, 18:CD003410.
   Google Scholar
• Ferri, M., Davoli, M., Peruccu, C. A. (2006). Heroin maintenance treatment for chronic heroin-dependent individuals: a Cochrane systematic review of effectiveness. Journal of Substance Abuse Treatment, 30:63–72.
   PubMed Web of Science ®Google Scholar
• Fhima, A., Henrion, R., Lowenstein, W., Charpak, Y. (2001). Two-year follow-up of an opioid-user cohort treated with high-dose buprenorphine (Subutex). Annales de Medicine Interne, 152(Suppl. 3):IS26–IS36.
   PubMedGoogle Scholar
• Fischer, G., Gombas, W., Eder, H., Jagsch, R., Peternell, A., Stuhlinger, G., (1999). Buprenorphine versus methadone maintenance for the treatment of opioid dependence. Addiction, 94:1337–1347.
   PubMed Web of Science ®Google Scholar
• Fischer, G., Ortner, R., Rohrmeister, K., Jagsch, R., Baewert, A., Langer, M., (2006). Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study. Addiction, 101;275–281.
   PubMedGoogle Scholar
• Gerra, G., Borella, F., Zaimovic, A., Moi, G., Bussandri, M., Bubici, C., (2004). Buprenorphine versus methadone for opioid dependence: predictor variables for treatment outcome. Drug and Alcohol Dependence, 75:37–45.
   PubMed Web of Science ®Google Scholar
• Ghodse, A. H., Reynolds, M., Baldacchino, A. M., Dunmore, E., Byrne, S., Oyefeso, A., (2002). Treating an opiate-dependent opiate-dependent inpatient population: a one-year follow-up study of treatment completers and noncompleters. Addictive Behaviors, 27:765–778.
   PubMed Web of Science ®Google Scholar
• Giacomuzzi, S. M., Ertl, M., Kemmler, G., Riemer, Y., Vigl, A. (2005). Sublingual buprenorphine and methadone maintenance treatment: a three-year follow-up of quality of life assessment. Scientific World Journal, 5:452–468.
   Web of Science ®Google Scholar
• Giacomuzzi, S. M., Riemer, Y., Ertl, M., Kemmler, G., Rossler, H., Hinterhuber, H., (2003). Buprenorphine versus methadone maintenance treatment in an ambulant setting: a health-related quality of life assessment. Addiction, 98:693–702.
   PubMed Web of Science ®Google Scholar
• Gibson, A. E., Doran, C. M., Bell, J. R., Ryan, A., Lintzeris, N. (2003). A comparison of buprenorphine treatment in clinic and primary care settings: a randomised trial. Medicine Journal of Australia, 179:38–42.
   PubMed Web of Science ®Google Scholar
• Goldberg, D. P., Williams, P. A. (1988). Users guide to the General Health Questionnaire: GHQ. Windsor, UK: NFER-NELSON.
   Google Scholar
• Gossop, M., Marsden, J., Stewart, D., Kidd, T. (2003). The National Treatment Outcome Research Study (NTORS): 4–5 year follow-up results. Addiction, 98:291–303.
   PubMed Web of Science ®Google Scholar
• Gossop, M., Marsden, J., Stewart, D., Rolfe, A. (1999). Treatment retention and 1 year outcomes for residential programmes in England. Drug and Alcohol Dependence, 57:89–98.
   PubMed Web of Science ®Google Scholar
• Guy, W. (1976). ECDEU assessment manual for psychopathology. U.S. Department of Health, Education and Welfare Publication (ADM) 76–388 (pp. 218–222, 534–537). Rockville, MD: National Institute of Mental Health.
   Google Scholar
• Ho, B. C., Nopoulos, P., Flaum, M., Arndt, S., Andreasen, N. C. (1998). Two-year outcome in first-episode schizophrenia: predictive value of symptoms for quality of life. American Journal of Psychiatry, 155:1196–1201.
   PubMed Web of Science ®Google Scholar
• Hubbard, R. L., Craddock, S. G., Flynn, P. M., Anderson, J., Etheridge, R. M. (1997). Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors, 11:261–278.
   Web of Science ®Google Scholar
• Jasinski, D. R., Pevnick, J. S., Griffith, J. D. (1978). Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction. Archives of General Psychiatry, 35:501–516.
   PubMed Web of Science ®Google Scholar
• Johnson, R. E., Jaffe, J. N., Fudala, P. J. (1992). A controlled trial of buprenorphene treatment for opioid dependence. Journal of American Medical Asociation, 267:2750–2755.
   PubMed Web of Science ®Google Scholar
• Kakko, J., Svanborg, K. D., Kreek, M. J., Heilig, M. (2003). 1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial. Lancet, 361:662–668.
   PubMed Web of Science ®Google Scholar
• Koivumaa-Honkanen, H. T., Honkanen, R., Antikainen, R., Hintikka, J., Viinamaki, H. (1999). Self-reported life satisfaction and treatment factors in patients with schizophrenia, major depression and anxiety disorder. Acta Psychiatrica Scandinavica, 99:377–384.
   PubMed Web of Science ®Google Scholar
• Kosten, T. R., George, T. P. (2002). The neurobiology of opioid dependence: implications for treatment. Science & Practice Perspectives, 13:13–20.
   Google Scholar
• Kosten, T. R., Schottenfeld, R., Ziedonis, D., Falcioni, J. (1993). Buprenorphine versus methadone maintenance for opioid dependence. Journal of Nervous and Mental Disease, 181:358–364.
   PubMed Web of Science ®Google Scholar
• Ling, W., Charuvastra, C., Collins, J. F., Batki, S., Brown, L. S., Jr., Kintaudi, P., (1998). Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial. Addiction, 93:475–486.
   PubMed Web of Science ®Google Scholar
• Ling, W., Wesson, D. R., Charuvastra, C., Klett, C. J. (1996). A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. Archives of General Psychiatry, 53:401–407.
   PubMed Web of Science ®Google Scholar
• Macdonald, E. M., Pica, S., Mcdonald, S., Hayes, R. L., Baglioni, A. J., Jr. (1998). Stress and coping in early psychosis. Role of symptoms, self-efficacy, and social support in coping with stress. British Journal of Psychiatry, 172(Suppl. 33):122–127.
   Google Scholar
• Marsch, L. A., Stephens, M. A., Mudric, T., Strain, E. C., Bigelow, G. E., Johnson, R. E. (2005). Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence. Experimental Clinical Psychopharmacology, 13:293–302.
   PubMed Web of Science ®Google Scholar
• Mattick, R. P., Breen, C., Kimber, J., Davoli, M. (2003). Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Review, The Cochrane Library, Issue 3, Oxford, Software update.
   Google Scholar
• Mattick, R. P., Kimber, J., Breen, C., Davoli, M. (2003). Buprenorphine maintenance versus placebo or methadone maintenance for opioid deprendence. Cochrane Review. The Cochrane Library, Issue 3, Oxford, Software update.
   Google Scholar
• McDowell, D. M., Cocke, C. (2006). Office-based treatment of opiate-dependent patients with buprenorphine: its about time. Primary Psychiatry, 13:68–73.
   Google Scholar
• Metzger, D. S., Navaline, H., Woody, G. E. (1998). Drug abuse treatment as AIDS prevention. Public Health Reports, 113(Suppl. 1):97–106.
   PubMed Web of Science ®Google Scholar
• Middel, B., Stewart, R., Bouma, J., (2001). How to validate clinically important change in health-related functional status. Is the magnitude of the effect size consistently related to magnitude of change as indicated by a global question rating?? Journal of Evaluation in Clinical Practice, 7:399–410.
   PubMed Web of Science ®Google Scholar
• Montoya, I. D., Schroeder, J. R., Preston, K. L., Covi, L., Umbricht, A., Contoreggi, C., (2005). Influence of psychotherapy attendance on buprenorphine treatment outcome. Journal of Substance Abuse Treatment, 28:247–254.
   PubMed Web of Science ®Google Scholar
• Nestler, E. J. (1997). Basic neurobiology of opiate addiction. In S. M. Stine & T. R. Kosten (Eds.), New treatments for opiate dependence (p. 286). New York: Guilford Press.
   Google Scholar
• Nestler, E. J., Aghajanian, G. K. (1997). Molecular and cellular basis of addiction. Science, 278:58–63.
   PubMed Web of Science ®Google Scholar
• Nigam, A. K., Ray, R., Tripathi, B. M. (1993). Buprenorphine in opiate withdrawal: a comparison with clonidine. Journal of Substance Abuse Treatment, 10:391–394.
   PubMed Web of Science ®Google Scholar
• O’Connor, P. G., Fiellin, D. A. (2000). Pharmacologic treatment of heroin-dependent patients. Annals of Internal Medicine, 133:40–54.
   PubMed Web of Science ®Google Scholar
• O’Connor, P. G., Oliveto, A. H., Shi, J. M., Triffleman, E. G., Carroll, K. M., Kosten, T. R., (1998). A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic. American Journal of Medicine, 105:100–105.
   PubMed Web of Science ®Google Scholar
• Ponizovsky, A. M., Grinshpoon, A., Margolis, A., Cohen, R., Rosca, P. (2006). Well-being, psychosocial factors, and side-effects among heroin-dependent inpatients after detoxification using buprenorphine versus clonidine. Addictive Behaviors, 31:2002–2013.
   PubMed Web of Science ®Google Scholar
• Ponizovsky, A., Grinshpoon, A., Sasson, R., Levav, I. (2004). Stress in adult students with schizophrenia in a supported education program. Comprehensive Psychiatry, 45:401–407.
   PubMedGoogle Scholar
• Ritsner, M., Modai, I., Endicott, J., Rivkin, O., Nechamkin, Y., Barak, P., (2000). Differences in quality of life domains and psychopathologic and psychosocial factors in psychiatric patients. Journal of Clinical Psychiatry, 61:880–889.
   PubMed Web of Science ®Google Scholar
• Ritsner, M., Ponizovsky, A., Endicott, J., Nechamkin, Y., Rauchverger, B., Silver, H., (2002). The impact of adverse events of antipsychotics on life satisfaction of schizophrenia patients: a naturalistic study. European Neuropsychopharmacology, 12:31–38.
   PubMed Web of Science ®Google Scholar
• Schottenfeld, R. S., Pakes, J. R., Kosten, T. R. (1998). Prognostic factors in buprenorphine- versus methadone-maintained patients. Journal of Nervous and Mental Disease, 186:35–43.
   PubMed Web of Science ®Google Scholar
• Schwarzer, R., Jerusalem, M. (1995). Generalized Self-Efficacy scale. In J. Weinman, S. Wright, & M. Johnston, (Eds.), (Measures in health psychology: a user's portfolio. Causal and control beliefs (pp. 35–37). Windsor, UK: NFER-NELSON.
   Google Scholar
• Sees, K. L., Delucchi, K. L, Masson, C., Rosen, A., Clark, H. W. (2000). Methadone maintenance versus 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trail. Journal of American Medical Association, 283:303–1310.
   Web of Science ®Google Scholar
• Seifert, J., Metzner, C., Paetzold, W., Borsutzky, M., Ohlmeier, M., Passie, T., (2005). Mood and affect during detoxification of opiate addicts: a comparison of buprenorphine versus methadone. Addiction Biology, 10:157–164.
   PubMedGoogle Scholar
• Shaham, Y., Erb, S., Stewart, J. (2000). Stress-induced relapse to heroin and cocaine seeking in rats: a review. Brain Research Reviews, 33:13–33.
   PubMed Web of Science ®Google Scholar
• Simoens, S., Matheson, C., Bond, C., Inkster, K., Ludbrook, A. (2005). The effectiveness of community maintenance with methadone or buprenorphine for treating opiate dependence. British Journal of General Practice, 55:139–146.
   PubMed Web of Science ®Google Scholar
• Smyth, B. P., Barry, J., Lane, A., Cotter, M., O’Neill, M., Quinn, C., et al. (2005). In-patient treatment of opiate dependence: medium-term follow-up outcomes. British Journal of Psychiatry, 187:360–365.
   PubMed Web of Science ®Google Scholar
• Soyka, M., Penning, R., Wittchen, U. (2006). Fatal poisoning in methadone and buprenorphine treated patients—are there differences?? Pharmacopsychiatry, 39:85–87.
   PubMed Web of Science ®Google Scholar
• Stein, M. D., Cioe, P., Friedmann, P. D. (2005). Buprenorphine retention in primary care. Journal of General Internal Medicine, 20:1038–1041.
   PubMed Web of Science ®Google Scholar
• Strain, E. C., Stitzer, M. L., Liebson, I. A., Bigelow, G. E. (1994). Comparison of buprenorphine and methadone in the treatment of opioid dependence. American Journal of Psychiatry, 151:1025–1030.
   PubMed Web of Science ®Google Scholar
• Strain, E. C., Stitzer, M. L., Liebson, I. A., Bigelow, G. E. (2002). Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index. Journal of Clinical Psychopharmacology, 16:58–67.
   Google Scholar
• Sullivan, L. E., Chawarski, M., O’Connor, P. G., Schottenfeld, R. S., Fiellin, D. A. (2005). The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment?? Drug and Alcohol Dependence, 79:113–116.
   PubMed Web of Science ®Google Scholar
• Testa, M. A., Simonson, D. C. (1996). Assessment of quality of life outcomes. New England Journal of Medicine, 334:835–840.
   PubMed Web of Science ®Google Scholar
• Torrens, M., Domingo-Salvany, A., Alonso, J., Castillo, C., San, L. (1999). Methadone and quality of life. Lancet, 353:1101.
   PubMed Web of Science ®Google Scholar
• Torrens, M., San, L., Martinez, A., Castillo, C., Domingo-Salvany, A., Alonso, J. (1997). Use of the Nottingham Health Profile for measuring health status of patients in methadone maintenance treatment. Addiction, 92:707–716.
   PubMed Web of Science ®Google Scholar
• Turner, R. J., Marino, F. (1994). Social support and social structure: a descriptive epidemiology. Journal of Health and Social Behavior, 35:193–212.
   PubMed Web of Science ®Google Scholar
• van de Velde, J. C., Schaap, G. E., Land, H. (1998). Follow-up at a Dutch addiction hospital and the effectiveness of therapeutic community treatment. Substance Use and Misuse, 33:1611–1627.
   PubMed Web of Science ®Google Scholar
• Walsh, S. L., June, H. L., Schuh, K. J., Preston, K. L., Bigelow, G. E., Stitzer, M. L. (1995). Effects of buprenorphine and methadone in methadone-maintained subjects. Psychopharmacology, 119:268–276.
   PubMed Web of Science ®Google Scholar
• Wilson, I. B., Cleary, P. D. (1995). Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. Journal of American Medical Association, 273:59–65.
   PubMed Web of Science ®Google Scholar
• Zimet, G. D., Dahlem, N. W., Zimet, S. G., Farley, G. K. (1988). The Multidimensional Scale of Perceived Social Support. Journal of Personality Assessment, 52:30–41.
   Web of Science ®Google Scholar